Anticonvulsants in the treatment of bipolar mania

Bibliography

• POST RM, BALLENGER JC, UHDE TW et al.: Efficacy of carbamazepine in manic-depressive illness: implications for underlying mechanisms. In: Neurobiology of Mood Disorders. Post RM, Ballenger J (Eds). Williams & Wilkins, Baltimore, MD (1984):777-816.
   Google Scholar
• POST RM, TRIMBLE MR, PIPPENGER CE: Clinical use of anticonvulsants in psychiatric disorders. Demos Publications, New York, NY (1989).
   Google Scholar
• Physicians’ Desk Reference, 59th edn. Thomson PDR, Montvale, NJ (2005).
   Google Scholar
• GOODNICK PJ (Ed.): Mania: Clinical & Research Perspectives. American Psychiatric Press, Washington, DC (1998).
   Google Scholar
• WEISLER RH, KALALI AH, KETTER TA et al.: A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J. Clin. Psychiatry (2004) 65:478-484.
   PubMed Web of Science ®Google Scholar
• WEISLER RH, KECK PE JR, SWANN AC et al.: Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry (2005) 66:323-330.
   PubMed Web of Science ®Google Scholar
• POPE HG JR, MCELROY SL, KECK PE JR et al.: Valproate in the treatment of acute mania. Arch. Gen. Psychiatry (1991) 48:62-68.
   PubMed Web of Science ®Google Scholar
• BOWDEN CL, BRUGGER AM, SWANN AC et al.: Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA (1994) 271(12):918-924.
   PubMed Web of Science ®Google Scholar
• MULLER AA, STOLL KD: Carbamazepine and oxcarbazepine in the treatment of manic syndromes – studies in Germany. In: Anticonvulsants in affective disorders. Emrich HM, Okuma T, Muller AA (Eds) Excerpta Medica, Amsterdam (1984).
   Google Scholar
• HUMMEL B, WALDEN J, STAMPFER R et al.: Acute antimanic efficacy and safety of oxcarbazepine inan open trial with an on-off-on design. Bipolar Disorders (2002)4:412-417.
   PubMed Web of Science ®Google Scholar
• ICHIM L, BERK M, BROOK S: Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann. Clin. Psychiatry (2000) 12(1):5-10.
   PubMedGoogle Scholar
• FRYE MA, KETTER TA, KIMBRELL TA et al.: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J. Clin. Psychopharmacol. (2000) 20:607-614.
   PubMed Web of Science ®Google Scholar
• PANDE AC, CROCKATT JG, JANNEY CA et al.: Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Bipolar Disord. (2000) 2(3 Pt. 2):249-255.
   PubMed Web of Science ®Google Scholar
• GRUNZE H, ERFURTH A, MARCUSE A et al.: Tiagabine appears not to be efficacious in the treatment of acute mania. J Clin Psychiatry (1999) 60:759-762.
   PubMed Web of Science ®Google Scholar
• SUPPES T, CHISHOLM KA, DHAVALE D et al.: Tiagabine in treatment refractory bipolar disorder: a clinical case series. Bipolar Disorders (2002) 4:283-289.
   PubMed Web of Science ®Google Scholar
• POWERS PS, SACHS GS, KUSHNER SF et al.: Topiramate in adults with acute bipolar I mania: pooled results. 157th Annual Meeting of the American Psychiatric Association. New York, NY (1 – 6 May 2004) NR365.
   Google Scholar
• POST RM, ALTSHULER LL, FRYE MA et al.: Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. J. Clin. Psychiatry (2005) 66:370-374.
   PubMed Web of Science ®Google Scholar
• GRUNZE H, LANGOSCH J, BORN C et al.: Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design. J. Clin. Psychiatry (2003) 64:781-784.
   PubMed Web of Science ®Google Scholar
• KANBA S, YAGI G, KAMIJIMA K et al.: The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog. Neuro-Psychopharmacol. & Biol. Psychiatry (1994) 18:707-715.
   PubMed Web of Science ®Google Scholar
• MCELROY SL, SUPPES T, KECK PE JR et al.: Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. J. Clin. Psychiatry (2005) 66:617-624.
   PubMed Web of Science ®Google Scholar
• GOODNICK PJ. Pharmacokinetic optimization of therapy with newer antidepressants. Clin. Pharmacokinet. (1994)27(4):307-330.
   PubMed Web of Science ®Google Scholar
• SHIRE US INC: Equetro™ (carbamazepine extended-release capsules) prescribing information. Shire US Inc., Wayne (PA) USA (2004).
   Google Scholar
• DEVANE CL: Pharmacokinetics, drug interactions, and tolerability of valproate. Psychopharmacol. Bull. (2003) 37(Suppl. 2):25-42.
   PubMedGoogle Scholar
• NATSCH S, HEKSTER YA, KEYSER A et al.: Newer anticonvulsant drugs. Drug Safety (1997) 17(4):228-240.
   PubMed Web of Science ®Google Scholar
• RASGON N: The relationship between polycystic ovary syndrome and antiepileptic drugs. J. Clin. Psychopharmacol. (2004) 24(3):322-334.
   PubMed Web of Science ®Google Scholar
• RASGON N, ALTSHULER LL, FAIRBANKS L et al.: Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disorders (2005) 7:246-259.
   PubMed Web of Science ®Google Scholar
• JOFFE H, COHEN LS, SUPPES T et al.: Polycystic ovarian syndrome is associated with valproate use in bipolar women. 157th Annual Meeting of the American Psychiatric Association. New York, NY (1 – 6 May 2004) NR264.
   Google Scholar
• WONG I CK, LHATOO SD: Adverse reactions to new anticonvulsant drugs. Drug Safety (2000) 23(1):35-56.
   PubMed Web of Science ®Google Scholar
• SCHAFFER LC, SCHAFFER CB, HOWE J: An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients. J. Affective Dis. (2002) 71:259-263.
   PubMed Web of Science ®Google Scholar
• ARNONE D: Review of the use of topiramate for treatment of psychiatric disorders. Arch. Gen. Psychiatry (2005) 4(5):1-14.
   Google Scholar
• RAMBECK B, WOLF P, SPECHT U: Pharmacokinetic interactions of the new antiepileptic drugs. Clin. Pharmacokinet. (1996) 31(4):309-324.
   PubMed Web of Science ®Google Scholar
• LEPPIK IE, WILLMORE LJ, HOMAN RW et al.: Efficacy and safety of zonisamide: results of a multi-centre study. Epilepsy Res. (1993) 14:165-173.
   PubMed Web of Science ®Google Scholar
• BOWDEN CL, CALABRESE JR, SACHS G et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry (2003) 60:392-400.
   PubMed Web of Science ®Google Scholar
• KAAJA E, KAAJA R, HIILESMAA V: Major malformations in offspring of women with epilepsy. Neurology (2003) 60:575-579.
   PubMed Web of Science ®Google Scholar
• KAPLAN PW: Reproductive health effects and teratogenicity and antiepileptic drugs. Neurology (2004) 63(Suppl. 4):S13-S23.
   PubMedGoogle Scholar
• KETTER TA, MANJI HK, POST RM: Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J. Clin. Psychopharmacol. (2003) 23(5):484-495.
   PubMed Web of Science ®Google Scholar
• MORROW JI, CRAIG JJ, RUSSELL AJC et al.: Which antiepileptic drugs are safest in pregnancy? Epilepsia (2003) 44(Suppl. 8):60.
   PubMedGoogle Scholar
• HIRSCHFELD RM, KECK PE JR, KRAMER M et al.: Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am. J. Psychiatry (2004) 161(6):1057-1065.
   PubMed Web of Science ®Google Scholar
• BALDESSARINI RJ, HENNEN J, WILSON M et al.: Olanzapine versus placebo in acute mania: treatment responses in subgroups. J. Clin. Psychopharmacol. (2003) 23(4):370-376.
   PubMed Web of Science ®Google Scholar
• KECK PE JR, VERSIANI M, POTKIN S et al.: Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry (2003) 160(4):741-748.
   PubMed Web of Science ®Google Scholar
• COHEN J: Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Erlbaum Associates, Inc., Hillsdale, NJ, USA (1998).
   Google Scholar